Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

NCT04886531 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2-positive Breast Cancer
ER Positive Breast Cancer
PR-Positive Breast Cancer

Interventions

DRUG: Neratinib
DRUG: Letrozole (L) or Anastrozole (A)
DRUG: Trastuzumab

Sponsor

Ruth O'Regan

Collaborators

[object Object]
[object Object]